Yet, we did not confirm that a higher peripheral CD4/CD8 T-cell ratio was associated with a better outcome (31, 33), and whether peripheral CD4/CD8 T-cell ratio reflects prognosis in COVID-19 deserves further studies. The gene discussed is CD4; the disease is COVID-19.